Hepatic Disorders

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Core Mechanism: Hepatic disorders lie on a spectrum from acute injury to chronic end-stage liver disease. Acute hepatic failure is driven by rapid hepatocellular necrosis (usually secondary to toxins like acetaminophen, viruses, or ischemic insults), presenting with the classic triad of jaundice, coagulopathy, and hepatic encephalopathy.
• The Cirrhotic Breakdown: Chronic liver disease (cirrhosis) occurs when normal hepatic parenchyma is progressively replaced by fibrotic scar tissue. This structural destruction creates immense vascular resistance, culminating in portal hypertension.
• The Domino Effect: Portal hypertension directly drives the formation of ascites and esophageal varices. Simultaneously, the loss of functional hepatocytes diminishes the liver's synthetic capacity (causing profound hypoalbuminemia and coagulopathy) and its clearance capacity (causing ammonia to cross the blood-brain barrier, leading to encephalopathy).
• The Renal Hit: The extreme splanchnic vasodilation and systemic hemodynamic shifts associated with liver failure cause renal hypoperfusion, eventually sparking hepatorenal syndrome—a highly lethal complication heralded by a rising serum creatinine.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Massive GI Bleed Stabilization: If the cirrhotic patient presents with acute variceal hemorrhage, establish two large-bore IVs and initiate rapid crystalloid volume resuscitation. Transfuse packed RBCs for a hemoglobin $\le$ 7 g/dL (or $\le$ 9 g/dL in older patients/those with comorbidities). If massive transfusion is required, use a balanced 1:1:1 ratio of PRBCs, platelets, and Fresh Frozen Plasma (FFP).
• Hepatic Encephalopathy Management: Assess the airway continuously. Correct precipitating triggers such as GI bleeding, hypokalemia, infection, or dehydration. Administer Lactulose (30–60 g/day) and Rifaximin (400 mg PO every 8 hours) to reduce ammonia burden.
• Ascites and Spontaneous Bacterial Peritonitis (SBP):
• Paracentesis: Perform an immediate diagnostic paracentesis if the patient has ascites and fever, abdominal pain, or unexplained clinical deterioration.
• Resuscitation: If performing a large-volume paracentesis (>5 L removed), administer 8 g of IV Albumin per liter of ascitic fluid removed to prevent circulatory compromise,.
• Antibiotics: Initiate empiric IV antibiotics for SBP. Cefotaxime 2 g IV every 8 hours for 5 days is the standard, though Ceftriaxone is also appropriate.
• Alcoholic Hepatitis: Calculate severity scoring; patients with severe alcoholic hepatitis warrant treatment with corticosteroids (Prednisone 40 mg PO daily or Methylprednisolone 32 mg IV daily).

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• "Can't-Miss" Mimics:
• Acute cholangitis or cholecystitis (biliary obstruction with infection).
• Budd-Chiari syndrome (portal vein thrombosis presenting with rapid onset hepatomegaly and ascites).
• Hepatic artery thrombosis (critical to suspect in liver transplant recipients presenting with fever/jaundice).
• HELLP syndrome (in pregnant patients in the late third trimester or postpartum period).
• Prioritized Diagnostic Workup:
• Core Labs: Complete blood count, comprehensive metabolic panel (including BUN/Cr to assess for hepatorenal syndrome), magnesium, and phosphorus.
• Hepatic specific: Fractionated bilirubin, transaminases (AST/ALT), alkaline phosphatase, and GGT (to confirm a biliary source of elevated Alk Phos),.
• Coagulation & Mental Status: PT/PTT, INR, and an Ammonia level if altered mental status is present.
• Ascitic Fluid Analysis: Send fluid for cell count and differential (EDTA tube), Gram stain, culture, total protein, albumin, and glucose,.
• Biomarker Cutoffs: Transaminases > 15x normal or approaching 10,000 IU/L strongly indicate severe acetaminophen toxicity or acute ischemic hepatopathy (shock liver),.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• POCUS Abdomen: Evaluate for anechoic free fluid (ascites) in Morison's pouch, the splenorenal recess, and the pelvis. Assess the liver for a "bright" appearance (microvesicular steatosis) or a nodular, shrunken appearance indicative of cirrhosis.
• Biliary Ultrasound: Visualize the gallbladder for wall thickening, pericholecystic fluid, and common bile duct dilation to rule out post-hepatic obstructive jaundice (e.g., choledocholithiasis),.
• Doppler Ultrasound: This is the gold-standard modality to emergently assess hepatic blood flow and rule out hepatic artery thrombosis in a post-transplant patient.
• ECG: Perform an ECG to rule out acute right heart failure (cor pulmonale) or ischemic events that can cause acute venous congestion or shock liver,.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• Model for End-Stage Liver Disease (MELD) Score: Utilizes serum creatinine, total bilirubin, INR, and sodium to predict 3-month mortality in patients with end-stage liver disease and helps determine transplant priority.
• Maddrey Discriminant Function (MDF): Incorporates coagulopathy and bilirubin levels to guide treatment in alcoholic hepatitis. A MDF score > 32 is the definitive threshold to initiate corticosteroid therapy.
• King's College Criteria: Identifies patients with acetaminophen-induced acute liver failure who require immediate liver transplant. Criteria include: pH < 7.3 (or lactate > 3.5 mmol/L) after resuscitation, OR the combination of Creatinine > 3.3 mg/dL, PT > 100s (INR > 5), and grade 3 or 4 encephalopathy.
• SBP Cutoff: An ascitic fluid granulocyte (neutrophil) count strictly greater than 250 cells/mm³ is the diagnostic threshold that mandates antibiotic treatment for Spontaneous Bacterial Peritonitis.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Deadly Cognitive Trap (Empiric Coagulopathy Correction): Administering FFP or Prothrombin Complex Concentrate (PCC) empirically to "fix" an elevated PT/INR in a bleeding cirrhotic patient. Correction: Coagulation studies in liver failure poorly represent actual bleeding risk. Administering FFP/PCC can dangerously increase thrombotic events and worsen portal hypertension, which actually exacerbates variceal bleeding.
• Deadly Cognitive Trap (Withholding Paracentesis): Delaying or withholding a diagnostic paracentesis due to an elevated INR or thrombocytopenia. Correction: An elevated INR or low platelets is not a contraindication to paracentesis in patients with cirrhosis.
• Critical Action (Beta-Blocker Cessation): Failing to discontinue nonselective beta-blockers in a cirrhotic patient diagnosed with SBP. Board examiners mandate you stop these drugs, as their continued use in decompensated SBP has been proven to significantly increase mortality,.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzwords:
• "Granulocyte/Neutrophil count > 250 cells/mm³" = Spontaneous Bacterial Peritonitis (SBP).
• "AST to ALT ratio > 2:1" = Alcoholic hepatitis.
• "Fever, jaundice, and RUQ pain in a recent liver transplant recipient" = Hepatic artery thrombosis.
• Classic Microbiology: The most common causative pathogens for SBP tested on exams are Escherichia coli and Klebsiella.
• Classic Distractor: A question describes an unstable cirrhotic patient with an upper GI bleed and an INR of 2.8, offering "Administer FFP" as a top option. Correction: The primary ED interventions proven to reduce mortality and rebleeding are early antibiotics (e.g., Ceftriaxone), a Proton Pump Inhibitor, and Octreotide—not FFP, unless adhering to a massive transfusion protocol,.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Resuscitation Hook: "This patient with a history of cirrhosis presents with new-onset fever, altered mental status, and ascites. My immediate concerns are Spontaneous Bacterial Peritonitis, Hepatic Encephalopathy, or an occult GI bleed. I will place the patient on continuous monitors, establish two large-bore IVs, and obtain a CBC, CMP including renal function, fractionated bilirubin, PT/INR, and an ammonia level."
• The Procedural Action: "I am performing a bedside ultrasound to confirm ascites and evaluate the liver architecture. I will then perform an immediate diagnostic paracentesis to obtain cell count and culture. I acknowledge that the patient's elevated INR is not a contraindication to this procedure."
• The Disposition & Management Plan: "Because the ascitic fluid neutrophil count is >250, I am diagnosing SBP. I will immediately start IV Cefotaxime. Because we removed over 5 liters of fluid, I am administering 8 grams of IV albumin per liter removed to prevent circulatory collapse and hepatorenal syndrome. I will also hold the patient's home beta-blocker to reduce mortality risk, start Lactulose for the encephalopathy, and consult Gastroenterology for ICU admission."